Results 251 to 260 of about 2,183,210 (336)

Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity¹ [PDF]

, 1998
Robert Hogikyan, Andrzej T. Gałecki, Bertram Pitt, Jeffrey B. Halter, Douglas A. Greene, Mark A. Supiano   +5 more
openalex   +1 more source

Bioinspired Adaptive Sensors: A Review on Current Developments in Theory and Application

Advanced Materials, EarlyView.
This review comprehensively summarizes the recent progress in the design and fabrication of sensory‐adaptation‐inspired devices and highlights their valuable applications in electronic skin, wearable electronics, and machine vision. The existing challenges and future directions are addressed in aspects such as device performance optimization ...
Guodong Gong, You Zhou, Qingxiu Li, Wenyu Zhao, Sunyingyue Geng, Hangfei Li, Yan‐Bing Leng, Shirui Zhu, Guanglong Ding, Yongbiao Zhai, Ziyu Lv, Ye Zhou, Su‐Ting Han   +12 more
wiley   +1 more source

Type 1 Diabetes Genetics Consortium.

J Clin Endocrinol Metab
Onengut-Gumuscu S, Concannon P, Akolkar B, Erlich HA, Julier C, Morahan G, Nierras CR, Pociot F, Todd JA, Rich SS.   +9 more
europepmc   +1 more source

Type 1 Diabetes/Hidradenitis Suppurativa Comorbidity-A Population-Based Study. [PDF]

J Clin Med
Sherman S, Slama R, Bar D, Schonmann Y, Cohen AD, Taieb YH, Mimouni D, Peretz A, Duskin-Bitan H.   +8 more
europepmc   +1 more source

Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas

Advanced Materials, EarlyView.
ENDO lipid nanoparticles containing cholecalciferol as a fifth component demonstrate mRNA delivery to the pancreas with 99% selectivity, including beta cells. This platform shows minimal toxicity and sustained protein expression for up to 3 days in a dose‐dependent manner, offering a novel approach to pancreas‐specific mRNA delivery and gene therapy ...
Ivan Isaac, Luv Patel, Nguyen Tran, Amarnath Singam, DongSoo Yun, Prasun Guha, Seungman Park, Chandrabali Bhattacharya   +7 more
wiley   +1 more source

Anlotinib induced type 1 diabetes: a case report. [PDF]

Front Oncol
Chen J, Xia D, Ke L.
europepmc   +1 more source

Retroviral Superantigens and Type 1 Diabetes Mellitus [PDF]

, 1998
Vincent J. Murphy, Leonard C. Harrison, William A. Rudert, Patrizia Luppi, Massimo Trucco, Alessandra Fierabracci, P A Biro, Gian Franco Bottazzo, Gian Franco Bottazzo   +8 more
openalex   +1 more source

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants [PDF]

, 2009
C. J. Greenbaum, D. Cuthbertson, Diabetes Prevention Trial-Type 1 Diabetes Study Gr, Eisenbarth, G. Eisenbarth, J. M. Sosenko, J. P. Krischer, J. P. Palmer, J. S. Skyler, L. E. Rafkin, Sherry, Skyler, Sosenko, Sosenko, The Diabetes Prevention Trial-Type 1 Study Group, Yalow, YU   +16 more
core   +2 more sources

Teplizumab: a promising intervention for delaying type 1 diabetes progression. [PDF]

Front Endocrinol (Lausanne)
Saleem MR, Khan MT.
europepmc   +1 more source

Life table analysis of the risk of Type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers

, 1992
I Deschamps, Christian Boîtard, J Hors, Marc Busson, A Marcelli-Barge, Alice Mogenet, Juliette Robert   +6 more
openalex   +1 more source